Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy
Condition(s):Nonsmall Cell Lung Cancer; Performance StatusLast Updated:November 7, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Nonsmall Cell Lung Cancer; Performance StatusLast Updated:November 7, 2023Recruiting
Condition(s):Non Small Cell Lung CarcinomaLast Updated:April 22, 2013Completed
Condition(s):Carcinoma, Non-Small-Cell LungLast Updated:April 30, 2010Completed
Condition(s):NSCLC Stage IV; NSCLC Stage IIIBLast Updated:January 17, 2024Active, not recruiting
Condition(s):Carcinoma, Non-Small-Cell LungLast Updated:November 29, 2023Active, not recruiting
Condition(s):Advanced Non Small Cell Lung CancerLast Updated:March 1, 2023Completed
Condition(s):MastitisLast Updated:August 20, 2014Completed
Condition(s):Non-Small Cell Lung CancerLast Updated:March 28, 2017Terminated
Condition(s):NSCLCLast Updated:November 24, 2020Terminated
Condition(s):Carcinoma, Non-Small-Cell LungLast Updated:December 7, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.